PSG.DE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 18:36):

Stats
Šios dienos apimtis	32.00
Vidutinė apimtis	520.00
Rinkos kapitalizacija	280.57M
EPS	€0 ( 2024-04-07 )
Kita pelno data	( €0 ) 2024-05-14
Last Dividend	€0.490 ( 2023-06-29 )
Next Dividend	€0 ( N/A )
P/E	18.72
ATR14	€0 (0.00%)

PharmaSGP Holding SE Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

PharmaSGP Holding SE Finansinės ataskaitos

Annual	2022
Pajamos:	€85.82M
Bruto pelnas:	€76.79M (89.48 %)
EPS:	€1.000

FY	2022
Pajamos:	€85.82M
Bruto pelnas:	€76.79M (89.48 %)
EPS:	€1.000

Financial Reports:

No articles found.

PharmaSGP Holding SE Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€0.490 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

PharmaSGP Holding SE Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.90 - Stable (1.97%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.450	2022-06-16
Last Dividend	€0.490	2023-06-29
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	€0.940	--
Avg. Dividend % Per Year	0.00%	--
Score	2.99	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.90
Div. Directional Score	8.25	--

Next Divdend (Est)
(2025-03-31)

€0.393 Estimate 3.00 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.99

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
MBG.DE	Ex Dividend Knight	2023-05-04	Annually	0.00%
47T.F	Ex Dividend Knight	2023-09-06	Annually	0.00%
VOS.DE	Ex Dividend Junior	2023-05-25	Sporadic	0.00%
EUZ.DE	Ex Dividend Knight	2023-06-08	Annually	0.00%
OEWA.DE	Ex Dividend Knight	2023-05-02	Annually	0.00%
ALD.DE	Ex Dividend Knight	2023-08-10	Quarterly	0.00%
HAG.DE	Ex Dividend Junior	2023-05-15	Annually	0.00%
RHK.DE	Ex Dividend Junior	2023-06-09	Sporadic	0.00%
BSL.DE	Ex Dividend Junior	2023-05-30	Annually	0.00%
IXX.DE	Ex Dividend Knight	2023-05-26	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.154	1.500	6.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.114	1.200	6.20	7.44	[0 - 0.3]
returnOnEquityTTM	0.451	1.500	6.10	9.15	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.56	0.800	2.21	1.766	[1 - 3]
quickRatioTTM	2.05	0.800	2.66	2.13	[0.8 - 2.5]
cashRatioTTM	1.546	1.500	2.52	3.78	[0.2 - 2]
debtRatioTTM	0.00766	-1.500	9.87	-10.00	[0 - 0.6]
interestCoverageTTM	5.89	1.000	8.93	8.93	[3 - 30]
operatingCashFlowPerShareTTM	2.18	2.00	9.27	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.12	2.00	8.94	10.00	[0 - 20]
debtEquityRatioTTM	0.0275	-1.500	9.89	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.906	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.246	1.000	7.08	7.08	[0.1 - 0.6]
cashFlowToDebtRatioTTM	25.94	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.742	0.800	8.39	6.71	[0.5 - 2]
Total Score				11.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	18.72	1.000	8.21	0	[1 - 100]
returnOnEquityTTM	0.451	2.50	7.49	9.15	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.12	2.00	9.29	10.00	[0 - 30]
dividendYielPercentageTTM	2.09	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.18	2.00	9.27	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.268	1.000	5.81	0	[0.1 - 0.5]
Total Score				4.90

PharmaSGP Holding SE

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.